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Abstract – The objective of this work was to investigate the presence of bovine herpesvirus type 1 (BoHV‑1) 
in follicular fluid and in cumulus‑oocyte complexes (COC) recovered from naturally infected cows but with 
no clinical signs of the disease. Cows that were seropositive (n=38) or seronegative (n=8, control) to infectious 
bovine rhinotracheitis were selected after a serum neutralization test in microplates. The presence of the virus 
was investigated by PCR in COC and in follicular fluid. Viral DNA was not found in any of the samples. The 
obtained results suggest that serologically positive cows with no clinical signs of the disease offer negligible 
risk of transmitting BoHV‑1 by COC or follicular fluid.
Index terms: Bos indicus, follicular fluid, infectious bovine rhinotracheitis virus, transmission risk, viral DNA.
Herpesvírus bovino tipo 1 em complexos cumulus‑oócito coletados  
de vacas infectadas naturalmente
Resumo – O objetivo deste trabalho foi investigar a presença do herpesvírus bovino tipo 1 (BoHV‑1) no fluido 
folicular e em complexos cumulus‑oócito (COC) coletados de vacas naturalmente infectadas mas sem sinais 
clínicos da doença. Vacas soropositivas (n=38) ou soronegativas (n=8, controle) para o vírus da rinotraqueíte 
infecciosa bovina foram selecionadas por prova de soroneutralização em microplacas. A presença do vírus foi 
investigada por PCR em COC e fluido folicular. O DNA viral não foi encontrado em qualquer das amostras. 
Os resultados obtidos são indicativos de que vacas soropositivas, mas sem sinais clínicos da doença, oferecem 
risco negligível de transmissão do BoHV‑1 por COC ou fluido folicular.
Termos para indexação: Bos indicus, fluido folicular, vírus da rinotraqueíte infecciosa bovina, risco de 
transmissão, DNA viral.
Embryo transfer emerged as an alternative for 
animal germplasm exchange due to its low costs, 
better logistics, and, mainly, lower sanitary risks, 
when compared to the trade of live animals (Thibier 
& Nibart, 1987). However, most of the scientific 
background supporting the international regulation for 
embryo transfer was formed before the increase in the 
use of in vitro embryo technologies in the last decade 
(Viana et al., 2012). During this period, there was also 
an alarming reduction in scientific literature about the 
biological safety of embryo transfer (Blondin, 2014).
The effectiveness of trypsin washing for 
decontamination of in vitro‑produced embryos is 
controversial (Wrathall et al., 2006; D’Angelo et al., 
2009). Consequently, risk analysis should focus on the 
chance of contamination of the gametes before embryo 
production. The development of strategies to investigate 
the presence of pathogens in the cumulus‑oocyte 
complexes (COC) is, therefore, critical for the safety 
of in vitro‑produced embryos.
Infectious bovine rhinotracheitis (IBR) is a disease 
caused by bovine herpesvirus type 1 (BoHV‑1), and it 
causes great economic losses both in the dairy and beef 
industries worldwide (Muylkens et al., 2007). In cattle 
experimentally infected with BoHV‑1, the virus was 
detected in embryos and follicular fluid; however, the 
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virus was not found in embryos produced in vitro from 
dexamethasone‑treated seropositive cows (Bielanski 
& Dubuc, 1994). The results of artificial infections in 
vitro are also controversial, since the virus was found 
in the embryos (Givens & Marley, 2008), but the 
amount of viral particles used is usually much higher 
than that occurring in natural infections. Moreover, it 
is very unlikely that a donor would be aspirated during 
the acute phase of the infection.
The objective of this work was to investigate the 
presence of BoHV‑1 in the follicular fluid and in COC 
recovered from naturally infected cows but with no 
clinical signs of the disease.
Naturally infected and seropositive (n=38) or 
seronegative (n=8) Gir cows (Bos indicus) were selected 
from herds located in the southeastern region of the 
state of Minas Gerais, Brazil, during 2006–2007. The 
animals were raised in grazing systems and were never 
vaccinated for IBR. All cows were also evaluated for 
the occurrence of clinical signs of the disease, such as 
fever, abnormal breathing, spontaneous cough, ocular 
and nasal discharges, flow of saliva, conjunctivitis, and 
hyperemia of the nasal mucosae; however, none of the 
cows showed any of these clinical signs.
Blood samples were collected 60 days before and 
on the day of follicular aspiration. The serological 
diagnosis of BoHV‑1 and of Bovine viral diarrhea 
virus (BVDV) was performed with the reference 
serum‑neutralization method using the Colorado strain 
of BoHV‑1 (ATCC VR 864) and Madin‑Darby bovine 
kidney (MDBK) cells (ATCC CCL 22). The final point 
of the reaction was determined as the serum’s highest 
dilution that was able to inhibit 100% of the cytopathic 
effect induced by BoHV‑1 in the MDBK cells. An 
animal was considered as seropositive when serum 
title was ≥4.0.
COC and samples of follicular fluid were recovered 
by transvaginal ultrasound‑guided follicle aspiration. 
The COC recovered were identified under 40x 
magnification and morphologically classified as 
“viable” or “nonviable”. A pool of COC and the 
samples of follicular fluid from each donor were stored 
in liquid nitrogen.
DNA extraction was performed using the commercial 
Biosystems DNA extraction kit (Biosystems, 
Curitiba, PR, Brazil), according to the manufacturer’s 
instructions. Identification of virus particles was 
performed by the PCR technique. The primers used 
and the amplification conditions are described in 
Alegre et al. (2001). Briefly, reactions were performed 
in a volume of 50 µL, with 10 µL DNA, Taq buffer – 
10 mmol L‑1 Tris HCL pH 9.0, 1.5 mmol L‑1 MgCl2, 
200 µmol L‑1 of dNTPs, 5% glycerol, and 2.5 U Taq 
DNA polymerase (Phoneutria Biotecnologia e Serviços 
Ltda., Belo Horizonte, MG, Brazil) – and 50 pmol 
of one of the sense or antisense primers (primer 1: 
5’‑AGACCCCAGTTGTGATGAATGC‑3’; and 
primer 2: 5’‑ACACGTCCAGCACGAACACC‑3’), 
which amplify a 183‑bp fragment of the BoHV‑1 
thymidine kinase gB gene. A mix of reagents (without 
DNA) and milli‑Q water, as well as a sample of 
an animal not exposed to BoHV‑1, were used as 
negative controls. Amplified fragments were analyzed 
by electrophoresis in 1% agarose gel containing 
Tris‑borate‑EDTA buffer (0.045 mol L‑1 Tris‑borate, 
1.0 mmol L‑1 EDTA, pH 7.2), at a voltage designed 
for the gel dimensions (1.0 to 10 V cm‑1 of gel), and 
were then stained with ethidium bromide. A molecular 
weight marker with 100‑bp increments 100‑bp ladder, 
(Invitrogen, ThermoFisher Scientific Inc., Waltham, 
MA, USA) was used as size standard.
The analytic sensitivity of the PCR method was 
evaluated using negative bovine follicular fluid and 
oocytes infected with serial ten‑fold dilutions of 
BoHV‑1 Colorado strain (ATCC VR‑864). Briefly, 
MDBK cells containing 105.4 TCID 50 mL‑1 of BoHV‑1 
were ten‑fold serially diluted with negative bovine 
follicular fluid and with oocytes from serologically 
negative cows. The analytic sensitivity of the PCR in 
COC and in follicular fluid was 10‑2 TCID 50 mL‑1. The 
COC recovery rates in seropositive and seronegative 
cows were compared by chi‑square analysis. The 
number of COC classified as viable or nonviable for 
in vitro embryo production was analyzed by analysis 
of variance (Anova), and means were compared by 
the t test using the SAS software, version 8.02 (SAS 
Institute Inc., Cary, NC, USA). Statistical significance 
was based on a p‑value of 5% probability.
The COC recovery rate was similar (p>0.05) 
between seronegative (control, 81.73%, i.e., 94 of 
115 follicles) and seropositive animals (72.25%, i.e., 
349 of 483 follicles). The average number of viable 
(5.12±2.53 vs. 4.47±3.02) and degenerated (6.62±2.55 
vs. 4.71±2.75) COC did not differ between the two 
groups (p>0.05). Although it was not designed for 
this purpose, the present study indirectly evaluated 
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the effect of BoHV‑1 infection on COC quality 
(mainly affected by follicular wave status, and follicle 
dominance or atresia), but the obtained results did 
not provide any evidence of the detrimental effects 
of IBR contamination on COC recovered from cows 
with different viral titles, but showing no clinical signs 
of the disease. The associations among viral titles, 
number, and quality grade of the COC recovered are 
shown in Table 1.
In the present study, all samples of follicular fluid 
and of COC, either from seronegative or seropositive 
cows, were negative to BoHV‑1 in the PCR reaction. 
These results are in alignment with the previous 
reports that in vivo‑derived embryos recovered from 
IBR serologically‑positive animals had no effect on 
pregnancy rates and did not contaminate recipients 
(Stringfellow & Wrathall, 1995), and also that in 
vitro‑produced embryos from serologically‑positive 
heifers tested negative for BoHV‑1 (Bielanski & 
Dubuc, 1994).
The present study was designed to reproduce the 
most common situation in the commercial embryo 
industry practice, in which seropositive donors were 
infected naturally and showed no clinical signs of the 
disease when aspirated. Other studies investigated the 
presence of virus particles in follicular fluid and in 
COC recovered from animals artificially infected, or 
naturally infected but in the acute period of the disease 
(Bielanski et al., 1993; Bielanski & Dubuc, 1994; 
Stringfellow & Givens, 2000). The level of infectivity 
in all these experimental models is unlikely to occur in 
naturally infected animals out of the acute phase of the 
disease, when the virus spreads and contaminates the 
reproductive tract (Guerin et al., 1997). Therefore, the 
obtained results bring an important contribution to the 
risk analysis of in vitro‑produced embryos.
It is also vital to consider the possibility of 
false‑negative results. This may occur due to PCR 
sensitivity, which is affected by the primers and 
procedures used, including the case of BoHV‑1 
(Marley et al., 2008). In the present study, the analytic 
sensitivity of the PCR reaction was shown to be 
high, even in the presence of a very small amount of 
viruses, as previously reported (Alegre et al., 2001). 
The speculative possibility of not detecting BoHV‑1 in 
samples with very low concentration of viral particles 
would also be associated with a contamination potential 
below the minimum threshold to cause infection, as 
found for other viruses (Gard et al., 2009). Therefore, 
the relevance of eventual false‑negative tests is low, and 
the screening of COC and of follicular fluid for BoHV‑1 
using PCR probably represents an alternative protocol 
to reduce the potential risk of disease transmission by 
the transfer of in vitro‑derived embryos.
In conclusion, these results suggest that serologically 
positive cows with no clinical signs of the disease offer 
negligible risk of transmitting BoHV‑1 by COC or 
follicular fluid.
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